Queensland business grants - a post-election update
Grants Intellect Labs Grants Intellect Labs

Queensland business grants - a post-election update

With the election complete, various grant programs that were put on-hold have re-opened for applications. It’s important for businesses to be aware of these grant opportunities and the upcoming application deadlines, but also to understand the impacts a change of government might have on grant funding availability.

Read More
Reviewing the latest data on Australia's innovation performance.
Research and Development Stephanie Varidel Research and Development Stephanie Varidel

Reviewing the latest data on Australia's innovation performance.

The outcomes from the latest Australian Innovation Statistics appear positive at first glance. In case you missed it, we provide a summary of the highlights from this recent report. We also dig a little deeper to see that despite some positive indications, there are some concerning signs regarding Australia's innovation performance that should provide pause for thought and consideration of how businesses undertaking R&D can be better supported.

Read More
Coming Soon: No Queensland State Government Grants
Grants Intellect Labs Grants Intellect Labs

Coming Soon: No Queensland State Government Grants

With the Queensland State Government election fast-approaching, it’s important that any Queensland businesses that are considering applying for state government funding understand what impact the election will have on grant programs. We’ve summarised our analysis of the impact that elections can have on the grant funding landscape, with a particular focus on the Queensland State Government election in October.

Read More
Upcoming Grant Opportunities from the Medical Research Future Fund (MRFF)
Grants Intellect Labs Grants Intellect Labs

Upcoming Grant Opportunities from the Medical Research Future Fund (MRFF)

The Medical Research Future Fund (MRFF) is a major source of health research funding in Australia, providing opportunities for both researchers and companies. The MRFF publishes funding rounds in advance, giving applicants reasonable notice to prepare. We have prepared an overview of upcoming grant opportunities, eligibility, and how Intellect Labs can support your submission.

Read More
Streamlining R&D Tax Claims for Clinical Trials in Australia
Research and Development Intellect Labs Research and Development Intellect Labs

Streamlining R&D Tax Claims for Clinical Trials in Australia

Clinical trials have long been viewed favourably under the R&D Tax Incentive Program. To recognise this, the program offers an efficient registration process for trials registered with the Therapeutic Goods Administration, reducing the administrative burden for biotech companies. This streamlined approach, along with support through Advance Overseas Findings (AOF), empowers Australian biotech firms to innovate and lead on the global stage.

Read More
How to Successfully Navigate the Overseas Finding Process for R&D Tax Incentives
Research and Development Intellect Labs Research and Development Intellect Labs

How to Successfully Navigate the Overseas Finding Process for R&D Tax Incentives

The Overseas Finding process is a crucial component of the Research & Development Tax Incentive (RDTI) in Australia, enabling companies to access a tax benefit for overseas activities that relate to an Australian R&D program. This guide explores the Overseas Finding process, the key conditions for eligibility, and recent ATO concerns as outlined in taxpayer alerts. We also highlight a successful case study with a cyber security innovator, Internet 2.0, to illustrate effective strategies for securing an Overseas Finding.

Read More
R&D Tax Incentives and the SME Turnover Dilemma
Research and Development Intellect Labs Research and Development Intellect Labs

R&D Tax Incentives and the SME Turnover Dilemma

The R&D Tax Incentive remains Australia’s primary program for supporting businesses undertaking R&D activities with an estimated $3.2 billion annual investment. The program uses a $20 million annual turnover threshold to determine a company’s R&D tax rebate, a threshold that has been unchanged since 2011. In our view, it is time to review this arbitrary line in the sand and ensure the R&DTI aligns with other SME policies so that highly innovative medium sized businesses are incentivised to continue their R&D investment as they grow.

Read More